Patients should also pay attention to other symptoms that accompany fatigue, such as dizziness, confusion, or palpitations, and seek medical advice promptly if these occur
Body composition is a primary consideration
28 Semaglutide is administered subcutaneously once-weekly at doses of 0.5 and 1.0 mg, with an initial dose of 0.25 mg/week for the first 4 weeks
Robyn Langham, TGA chief medical advisor: We are investigating a number of organisations that we have information on that are doing things that are outside of the legal exemptions in this area
Others experience persistent burping throughout treatment, particularly those with pre-existing digestive conditions
Well discuss your medical history and any concerns during the initial weight-loss appointment